Posted 1/10/2018 by hhill
First a reminder: After this posting, I will not be back on this blog until January 29th. I will try then to include a picture from our Antarctica adventure. I am very excited and a bit nervous about the Drake Passage crossing.Per my entry earlier this week, however, I am filled with determination to see as much of this gorgeous world as possible, and this very southern part is said to be other-worldly beautiful.
Today, still based in Boston, I am writing about new studies related to the optimal length of time for women with ER positive breast cancers to stay on AIs (aromatase inhibitors). As you may know, the original treatment was five years after completing chemotherapy or other initial breast cancer treatment. Since it had been learned that continuing Tamoxifen for a total of ten years, rather than the original five, reduced the recurrence and death rates, the question was whether something similar would be found with extending the duration of AI treatment.